Check whether a special treatment protects vein valves after clot
Part of Blood & lymphatic clinical trials.
This study enrolls people with an acute blood clot in the thigh or pelvis veins to see how well a procedure called PCDT (using a Zelante device) preserves the function of vein valves. It may help reduce complications like ongoing vein problems after a clot.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a new, painful blood clot (DVT) in a higher/upper leg or pelvis vein (femoral, popliteal, common femoral, or iliac veins).
- The clot is considered “proximal,” meaning it’s located closer to the body (not only in the calf).
- Your clot is treated with PCDT using the Zelante device.
- Your symptoms started within the last 14 days (you cannot have symptoms for more than 14 days).
- You may have other veins on the same side involved, but the main clot must be in the listed veins.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a procedure to remove blood clots from deep veins in the leg and pelvis. It aims to improve blood flow and reduce long-term leg damage. If you have a recent clot in these veins, you may be eligible.
This study tests a device that removes blood clots from the deep veins of your leg. It's designed to help people with recent or slightly older clots in the thigh or pelvic area, aiming to reduce symptoms and prevent complications.
This trial tests a device that removes blood clots from the deep veins of the leg (a condition called deep vein thrombosis or DVT). It aims to see if this procedure helps patients feel better and avoid complications compared to standard care.
This trial studies a procedure to remove an acute deep vein blood clot in the leg. It may help restore blood flow faster than standard treatment for certain clot locations.
This study compares two ways to treat a recent blood clot in the large veins of the leg. One approach uses standard blood thinners, and the other uses a procedure to suction the clot out plus blood thinners. The goal is to see which method better restores blood flow and reduces long-term leg damage.
This study tests whether an implanted “vein valve” system can improve blood flow in people with painful chronic venous valve leakage in the thigh/knee veins. It also checks if the procedure and follow-up are safe and workable, especially with blood-thinner medicines before and after.
Hear when a new Acute Deep Venous Thrombosis of Femoral Vein (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.